Why the study?
Does gliclazide improve glycaemic control and metabolic parameters in non-insulin-dependent diabetic patients?
Population
50 non-insulin-dependent diabetic patients, aged 59.06 +/- 1.37 years, overweight, with an impaired daily…
Design
Cohort
Follow-up
36 months
Authors
Loading...
Gliclazide may sustain glucose lowering in observational cohorts; leaves open confirmation of metabolic benefits in randomized trials.
Does gliclazide improve glycaemic control and metabolic parameters in non-insulin-dependent diabetic patients?
Long-term gliclazide therapy effectively improved glycaemic control, lipid profiles, and platelet adhesiveness without causing weight gain or hypoglycaemia in non-insulin-dependent diabetic patients.
Hernández et al. (1986) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: